医学
福莫特罗
哮喘
随机对照试验
梅德林
相对风险
不利影响
数据提取
生活质量(医疗保健)
内科学
儿科
布地奈德
置信区间
政治学
护理部
法学
作者
Daniel Rayner,Dario Ferri,Gordon H Guyatt,Paul M. O’Byrne,Romina Brignardello‐Petersen,Farid Foroutan,Bradley E. Chipps,Kaharu Sumino,Tamara T. Perry,Sharmilee M. Nyenhuis,John Oppenheimer,Elliot Israel,Flavia Hoyte,Katherine Rivera‐Spoljaric,Ellen McCabe,Susana Rangel,Lindsay Shade,Valerie G. Press,Lisa Hall,Dia Sue-Wah-Sing
出处
期刊:JAMA
[American Medical Association]
日期:2024-10-28
卷期号:333 (2): 143-143
被引量:38
标识
DOI:10.1001/jama.2024.22700
摘要
In this network meta-analysis of patients with asthma, ICS combined with formoterol and ICS combined with SABA were each associated with reduced asthma exacerbations and improved asthma control compared with SABA alone.
科研通智能强力驱动
Strongly Powered by AbleSci AI